Bo Liang Lou
Chief Executive Officer chez PHARMARON BEIJING CO., LTD.
Fortune : 509 M $ au 31/03/2024
Profil
Bo Liang Lou a fondé Pharmaron Beijing Co., Ltd. Actuellement, il est président et directeur général de cette société et président et directeur de Pharmaron, Inc. (une filiale de Pharmaron Beijing Co., Ltd.). Il est également membre du conseil d'administration de Pharmaron UK Ltd. et de Quotient Bioresearch (Rushden) Ltd. Dans sa carrière antérieure, il a été directeur de recherche chez Advanced Syntech, directeur de recherche chez Helios Health, Inc. et chercheur scientifique chez Cytel Corp. et Ontogen Corp. Il a obtenu un doctorat et un diplôme d'études supérieures de l'Institut de chimie organique de Shanghai.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
18/04/2024 | 180 496 500 ( 12,70% ) | 509 M $ | 31/03/2024 |
Postes actifs de Bo Liang Lou
Sociétés | Poste | Début |
---|---|---|
PHARMARON BEIJING CO., LTD. | Chief Executive Officer | 27/10/2016 |
Pharmaron, Inc.
Pharmaron, Inc. Medical/Nursing ServicesHealth Services Pharmaron, Inc. provides research and development services. It specializes in synthetic and medicinal chemistry, biology, DMPK, pharmacology, safety assessment, radiochemistry, and radiolabelled metabolism to chemical & pharmaceutical development. The company was founded on December 22, 2006 and is headquartered in Louisville, KY. | President | - |
Pharmaron UK Ltd.
Pharmaron UK Ltd. Pharmaceuticals: MajorHealth Technology Pharmaron UK Ltd. provides drug development services. It provides tailored solutions for pharmaceutical, biotechnology and agrochemical clients, using technologies underpinned by unparalleled medical, chemical and biologically. The company was founded in 2003 and is headquartered in Cardiff, the United Kingdom. | Director/Board Member | 02/02/2016 |
Quotient Bioresearch (Rushden) Ltd.
Quotient Bioresearch (Rushden) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pharmaron Beijing Co., Ltd., Quotient Bioresearch (Rushden) Ltd. provides environmental fate services. The private company is based in Hoddesdon, UK. | Director/Board Member | - |
Anciens postes connus de Bo Liang Lou
Sociétés | Poste | Fin |
---|---|---|
Ontogen Corp. | Corporate Officer/Principal | - |
Advanced Syntech | Chief Tech/Sci/R&D Officer | - |
Cytel Corp. | Corporate Officer/Principal | - |
Helios Health, Inc.
Helios Health, Inc. Medical/Nursing ServicesHealth Services Part of Helios Ventures, Inc., Helios Health, Inc. provides general medical services at kiosks in offices. The private company is based in Atlanta, GA. Helios Health was acquired by Helios Ventures, Inc. on August 23, 2001. | Chief Tech/Sci/R&D Officer | - |
Formation de Bo Liang Lou
Shanghai Institute of Organic Chemistry | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PHARMARON BEIJING CO., LTD. | Commercial Services |
Entreprise privées | 7 |
---|---|
Helios Health, Inc.
Helios Health, Inc. Medical/Nursing ServicesHealth Services Part of Helios Ventures, Inc., Helios Health, Inc. provides general medical services at kiosks in offices. The private company is based in Atlanta, GA. Helios Health was acquired by Helios Ventures, Inc. on August 23, 2001. | Health Services |
Ontogen Corp. | |
Cytel Corp. | |
Advanced Syntech | |
Pharmaron UK Ltd.
Pharmaron UK Ltd. Pharmaceuticals: MajorHealth Technology Pharmaron UK Ltd. provides drug development services. It provides tailored solutions for pharmaceutical, biotechnology and agrochemical clients, using technologies underpinned by unparalleled medical, chemical and biologically. The company was founded in 2003 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Pharmaron, Inc.
Pharmaron, Inc. Medical/Nursing ServicesHealth Services Pharmaron, Inc. provides research and development services. It specializes in synthetic and medicinal chemistry, biology, DMPK, pharmacology, safety assessment, radiochemistry, and radiolabelled metabolism to chemical & pharmaceutical development. The company was founded on December 22, 2006 and is headquartered in Louisville, KY. | Health Services |
Quotient Bioresearch (Rushden) Ltd.
Quotient Bioresearch (Rushden) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pharmaron Beijing Co., Ltd., Quotient Bioresearch (Rushden) Ltd. provides environmental fate services. The private company is based in Hoddesdon, UK. | Commercial Services |